Del Giacomo, Paola
 Distribuzione geografica
Continente #
NA - Nord America 259
EU - Europa 154
AS - Asia 26
AF - Africa 4
SA - Sud America 1
Totale 444
Nazione #
US - Stati Uniti d'America 258
SE - Svezia 60
IT - Italia 30
CN - Cina 18
IE - Irlanda 15
FR - Francia 14
DE - Germania 13
FI - Finlandia 8
GB - Regno Unito 6
IN - India 5
CI - Costa d'Avorio 4
BE - Belgio 3
UA - Ucraina 2
AT - Austria 1
BR - Brasile 1
CA - Canada 1
IL - Israele 1
IR - Iran 1
MK - Macedonia 1
NL - Olanda 1
PH - Filippine 1
Totale 444
Città #
Chandler 89
Ashburn 18
Dublin 15
San Mateo 14
Ann Arbor 13
Beijing 13
New York 10
Boston 8
Princeton 8
Helsinki 6
Wilmington 6
Fairfield 5
Marseille 5
Rome 5
Abidjan 4
Bremen 4
Jacksonville 4
Nanjing 4
Pune 4
Augusta 3
Brussels 3
Lawrence 2
Millbury 2
Mira 2
Pesaro 2
Seattle 2
Washington 2
Acton 1
Amsterdam 1
Berlin 1
Boardman 1
Bologna 1
Cagliari 1
Edinburgh 1
Florence 1
Houston 1
Kilburn 1
Leawood 1
London 1
Los Angeles 1
Manila 1
Milan 1
Mountain View 1
Norwalk 1
Pico Rivera 1
Prilep 1
Redwood City 1
Reggio Calabria 1
Saint Paul 1
San Diego 1
Scarmagno 1
São Paulo 1
Tel Aviv 1
Toronto 1
Vienna 1
Woodbridge 1
Zhengzhou 1
Totale 283
Nome #
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 60
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 58
The diagnosis of pneumonia in a pregnant woman with coronavirus disease 2019 using maternal lung ultrasound 52
The diagnosis of pneumonia in a pregnant woman with coronavirus disease 2019 using maternal lung ultrasound. 49
SARS-CoV-2 infection in a highly experienced person living with HIV 47
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 41
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 40
The role of carbapenem-resistant pathogens in cSSTI and how to manage them 37
Meropenem/ vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 36
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 35
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? 4
Totale 459
Categoria #
all - tutte 2.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202032 4 0 4 0 0 0 1 0 2 5 15 1
2020/202129 1 1 0 3 1 1 3 1 0 8 8 2
2021/2022117 7 1 1 14 6 6 1 19 4 5 30 23
2022/2023207 22 25 13 33 15 31 9 22 21 2 9 5
2023/202466 2 24 4 4 2 16 5 2 2 1 4 0
Totale 459